Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Jilin Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, General Hospital of the Yangtze River Shipping, Wuhan Brain Hospital, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Electrocardiography, Coronary Artery Disease, Action Potentials. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was supported by the effect of the NOD1/RIP2 signaling pathway on foam cell formation derived from THP-1 cells (grant no WX20Q10)..
Abstract (Originalsprache)
Background
Electrocardiographic parameters have emerged as valuable noninvasive markers for risk stratification in acute coronary syndrome (ACS).
Aims
This study aimed to evaluate the correlation between R wave peak time (RWPT) and coronary artery disease (CAD) severity, and to assess its prognostic value for in‐hospital major adverse cardiac events (MACE) in ACS patients.
Methods
We retrospectively analyzed 183 ACS patients who underwent coronary angiography at our hospital between January 2020 and December 2023. RWPT, QRS duration, and P wave peak time were measured from admission electrocardiograms. CAD severity was quantified using the Gensini score, with patients classified into mild (score < 25, n = 81) and moderate‐severe (score ≥ 25, n = 102) groups. In‐hospital MACE was systematically recorded during hospitalization.
Results
RWPT demonstrated a strong positive correlation with the Gensini score ( r = 0.7, p < 0.001). Patients with moderate‐severe CAD exhibited significantly prolonged RWPT compared to those with mild disease (43.2 ± 6.3 vs. 36.8 ± 5.3 ms, p < 0.001). Similarly, patients who experienced MACE had significantly longer RWPT than those without complications (44.7 ± 6.2 vs. 37.1 ± 5.5 ms, p < 0.001). In‐hospital MACE occurred in 25 patients (13.7%). Multivariate logistic regression analysis identified both RWPT (OR: 1.10, 95% CI: 1.05−1.15, p < 0.001) and diabetes mellitus (OR: 3.02, 95% CI: 1.16−7.93, p = 0.024) as independent risk factors of in‐hospital MACE.
Conclusion
RWPT measured on admission electrocardiograms correlates significantly with CAD severity and independently predicts in‐hospital MACE in ACS patients. As a simple, readily available parameter, RWPT may enhance risk stratification in ACS, particularly in resource‐limited settings where advanced imaging or biomarker testing access is constrained.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, General Hospital of the Yangtze River Shipping, Wuhan Brain Hospital, Wuhan, Hubei, China.
ORCID-Profile: Jing Han
Förderung
- This study was supported by the effect of the NOD1/RIP2 signaling pathway on foam cell formation derived from THP-1 cells (grant no WX20Q10).
Zitieren
APA
Xu, J., Yu, W., Li, X., Wu, X., Tan, B., & Han, J. (2025). Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31669
Vancouver
Xu J, Yu W, Li X, Wu X, Tan B, Han J. Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31669
BibTeX
@article{Xu2025,
author = {Xu, Jilin and Yu, Wen and Li, Xiuqi and Wu, Xingan and Tan, Baozhen and Han, Jing},
title = {Electrocardiographic R Wave Peak Time: Correlation With the Severity of Coronary Artery Disease and Prognosis in Patients With Acute Coronary Syndrome},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31669}
}
EUVIMED